1Department of Biostatistics, Johns Hopkins University, Baltimore, Maryland, USA. jane_2_xu@sbphrd.com
Using multiple biomarkers as surrogate endpoints can improve treatment effect inferences over single markers. This study introduces a joint model to assess the benefit of multiple surrogates in clinical trials.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: